FDA approves Allergan’s Botox for forehead wrinkles: 3 things to know

The Food and Drug Administration on Tuesday approved a new use for Botox treatment.

Advertisement

1. Botox may now be used for the temporary improvement of moderate to severe forehead lines.

2. The drug is already approved for use with crow’s feet lines and glabellar lines, also known as eyebrow wrinkles.

3. Botox represents the first neurotoxin treatment approved for use in three facial treatment areas.

More articles on supply chain:

Phoenix Children’s Hospital donates medical supplies to Hurricane Maria victims
FDA commissioner: High drug prices are a ‘public health concern the FDA should address’
FDA improves online adverse drug effects database

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.